Schedule 13D ownership disclosure

CHROMOCELL THERAPEUTICS CORP

Security class unavailable · CUSIP: 171126105

Event date: 2024-02-15

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001753926-24-000393
Form type
SC 13D
Filer
Pelthos Therapeutics Inc.
CIK
CIK 1919246
Filed
Feb 26, 2024
Reporting period
Feb 15, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub